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Abstract 
Metastatic cardiac lesions are often clinically 
silent, and incidence may be determined more 
accurately upon autopsy.1 Cardiac metastases 
have been identified by autopsy in up to 20% of 
patients who succumbed to cancer. Malignant 
melanoma, leukemia, and lymphoma are the 
most common primary cancers to spread to the 
heart; however, these cases of metastasis have 
decreased with improved chemotherapy 
regimens.2  
Few reports of cardiac metastasis due to colon 
cancer were found in the literature. This exhibit 
illustrates the case of a 65-year-old female 
patient with presumed metastatic disease to the 
heart from a primary colon malignancy. 
Image 1. Cardiac MRI identifying a 2.1 x 1.4 cm mass. 
Table 1. Treatment Summary.  
Discussion  
A 65 year old woman was diagnosed with a 
pT3(m) pN0 cM0, group IIA adenocarcinoma of 
the colon. A definitive subtotal colonectomy was 
performed.  One year later, she presented with an 
elevated carcinoembryonic antigen level, a 
hepatic lesion and a mass in the right ventricle 
(Image 1). 
Palliative radiation therapy was prescribed to 
decrease tumor size and to reduce the risk of 
pulmonary emboli or complications from a 
stroke. Table 1 shows the summary of the 
treatment prescription.  Image 2 illustrates the 
four field treatment plan with beam orientation 
and dose distribution.  
Figure 1 depicts the dose volume histogram 
which outlines the dose to the target volume and 
the normal, surrounding  tissue. The patient 
tolerated the  treatment well and the size of the 
cardiac tumor was decreased due to the treatment.  
Unfortunately, the patient did pass away prior to 
her 4 month follow-up due to the advanced 
disease.  
Image 2. Treatment plan showing beam orientation.  
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Literature Review 
Neoplasms tend to spread to the heart via one of 
four pathways: the lymphatic system, direct 
extension, hematogenous spread, or transvenous 
extension via the superior and inferior vena 
cava.3 
Factors that may explain the rarity of cardiac 
spread due to colorectal cancer include: 
• Strong kneading motion of the myocardium. 
• Rapid blood flow through the heart. 
• Flow of lymphatic drainage, which usually 
moves away from the heart. 
• Peculiar metabolic actions of striated muscle.4 
Palliative therapy is usually offered to patients 
who have been diagnosed with heart metastasis. 
Systemic chemotherapy is most beneficial.5 
Radiation therapy may be  administered to 
relieve symptoms or if other treatment modalities 
are not feasible.  
Treatment site        Right ventricle of the heart 
Total dose               1500 cGy 
Dose per fraction     300 cGy 
Technique              3-D conformal radiation therapy  
(LAO, RAO, RPO-260, RPO-225) 
Modality             6 MV and 15 MV x-rays 
Prescription         100% isodose line 
Treatment time        5 days Figure 1.  The DVH depicts 100% of the target 
volume (baby blue line) receiving between 1500-
1520cGy while less than 10% of the healthy heart 
(purple line) is receiving the 1450cGy of dose. 
Conclusion 
Less than 40% of colorectal cancer patients are 
diagnosed with early stage disease.  Only 33 states 
have legislation requiring insurance coverage for 
cancer screening.6,7  
 
The incidence of cardiac metastasis from colorectal 
cancer and other cancers is likely to increase with 
longer life expectancies.4 Continued improvements 
in imaging and treatment regimens may decrease 
cases of cardiac metastasis and improve overall 
survival rates. 
